Found: 31
Select item for more details and to access through your institution.
Automated and enhanced extraction of a small molecule-drug conjugate using an enzyme-inhibitor interaction based SPME tool followed by direct analysis by ESI-MS.
- Published in:
- Analytical & Bioanalytical Chemistry, 2019, v. 411, n. 28, p. 7387, doi. 10.1007/s00216-019-02165-7
- By:
- Publication type:
- Article
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 8, p. 2332, doi. 10.1007/s00259-024-06705-x
- By:
- Publication type:
- Article
Response to: GCP III is not the "off-target" for urea-based PSMA-ligands.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2947, doi. 10.1007/s00259-023-06302-4
- By:
- Publication type:
- Article
Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 3, p. 957, doi. 10.1007/s00259-022-05982-8
- By:
- Publication type:
- Article
Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1320524
- By:
- Publication type:
- Article
Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA-Encoded Self-Assembling Chemical Libraries.
- Published in:
- ChemMedChem, 2017, v. 12, n. 21, p. 1748, doi. 10.1002/cmdc.201700569
- By:
- Publication type:
- Article
Isolation of a Natural Killer Group 2D Small‐Molecule Ligand from DNA‐Encoded Chemical Libraries.
- Published in:
- ChemMedChem, 2022, v. 17, n. 21, p. 1, doi. 10.1002/cmdc.202200350
- By:
- Publication type:
- Article
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1934, doi. 10.2967/jnumed.123.266007
- By:
- Publication type:
- Article
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1852, doi. 10.2967/jnumed.122.264036
- By:
- Publication type:
- Article
A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264036
- By:
- Publication type:
- Article
A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264036
- By:
- Publication type:
- Article
A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264036
- By:
- Publication type:
- Article
A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264036
- By:
- Publication type:
- Article
A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 4, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.245530
- By:
- Publication type:
- Article
The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8<sup>+</sup> T cell activity and synergizes with immune checkpoint inhibitors.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 9, p. 2518, doi. 10.1002/ijc.32603
- By:
- Publication type:
- Article
Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 8, p. 958, doi. 10.3390/ph15080958
- By:
- Publication type:
- Article
Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis.
- Published in:
- Experimental Biology & Medicine, 2021, v. 246, n. 8, p. 940, doi. 10.1177/1535370220981578
- By:
- Publication type:
- Article
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 18, p. 10020, doi. 10.3390/ijms221810020
- By:
- Publication type:
- Article